New approaches for empiric therapy in Gram-positive sepsis

M Bassetti1, F Ginocchio, D R Giacobbe

  • 1Division of Infectious Diseases, San Martino Hospital and University of Genoa School of Medicine, Genoa, Italy. matteo.bassetti@hsanmartino.it

Insights

Nosocomial bloodstream infections (BSIs) are a significant threat in ICUs, often caused by antibiotic-resistant Gram-positive bacteria like MRSA. New antibacterials offer alternatives but require careful use due to potential resistance.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pharmacology

Background:

  • Nosocomial bloodstream infections (BSIs) are a major cause of illness and death in intensive care units (ICUs).
  • Gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA), are increasingly resistant to antibiotics, posing a significant challenge in ICUs.
  • Vancomycin, the standard treatment for MRSA, shows reduced effectiveness when its minimum inhibitory concentration (MIC) is high.

Purpose of the Study:

  • To review the microbiological, pharmacological, and clinical profiles of three novel antibacterials: linezolid, tigecycline, and daptomycin.
  • To highlight their utility in treating severe infections in ICU patients.
  • To emphasize the importance of understanding both existing and new antibiotics for effective management.

Main Methods:

  • Review of microbiological, pharmacological, and clinical data for linezolid, tigecycline, and daptomycin.
  • Analysis of current trends in antibiotic resistance among Gram-positive bacteria in ICUs.
  • Evaluation of vancomycin efficacy in relation to MIC values.

Main Results:

  • Linezolid, tigecycline, and daptomycin are identified as valuable agents for severe infections in ICUs.
  • The emergence of resistance to these new agents is a potential concern.
  • High prevalence of MRSA and the widespread use of vancomycin necessitate alternative treatment strategies.

Conclusions:

  • Effective management of BSIs in ICUs requires a comprehensive understanding of both traditional and novel antibacterial agents.
  • Careful consideration of antibiotic resistance patterns and drug efficacy is crucial for optimizing patient outcomes.
  • Linezolid, tigecycline, and daptomycin represent important additions to the therapeutic arsenal against resistant Gram-positive infections, but their use must be judicious to preserve efficacy.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...